SecSonar.com

Clover Health Investments, Corp. (CLOV)

Clover Health Investments, Corp. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Clover Health Investments, Corp. (CLOV) is a Medical - Healthcare Plans company based in US with a market capitalization of $2.1B. Revenue grew 40.3% year-over-year and free cash flow was negative at -$69M. This page tracks CLOV's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 570 employees · IPO Jun 12, 2020

Valuation

Valuation & price

$3.47 · as of May 17, 2026 · -35.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

6.84

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$5.41$3.56$1.72Jul 25Dec 25Jul 26Jul 7, 25$2.89Jul 9, 25$3.17Jul 11, 25$2.92Jul 15, 25$2.98Jul 17, 25$3.01Jul 21, 25$3.11Jul 23, 25$3.41Jul 25, 25$3.04Jul 29, 25$2.89Jul 31, 25$2.89Aug 4, 25$2.88Aug 6, 25$2.26Aug 11, 25$2.47Aug 13, 25$2.62Aug 15, 25$2.65Aug 19, 25$2.52Aug 21, 25$2.61Aug 25, 25$2.65Aug 27, 25$2.69Aug 29, 25$2.62Sep 3, 25$2.66Sep 5, 25$2.75Sep 9, 25$2.89Sep 11, 25$3.14Sep 16, 25$3.12Sep 18, 25$3.07Sep 22, 25$3.00Sep 24, 25$3.22Sep 26, 25$3.20Sep 30, 25$3.06Oct 2, 25$2.53Oct 6, 25$2.62Oct 8, 25$2.78Oct 10, 25$2.56Oct 14, 25$2.79Oct 16, 25$2.70Oct 21, 25$3.22Oct 23, 25$3.20Oct 27, 25$3.81Oct 29, 25$3.64Oct 31, 25$3.53Nov 4, 25$3.52Nov 6, 25$2.61Nov 10, 25$2.60Nov 12, 25$2.51Nov 14, 25$2.47Nov 18, 25$2.35Nov 20, 25$2.16Nov 25, 25$2.42Nov 28, 25$2.49Dec 2, 25$2.49Dec 4, 25$2.66Dec 8, 25$2.56Dec 10, 25$2.66Dec 12, 25$2.70Dec 16, 25$2.64Dec 18, 25$2.58Dec 22, 25$2.60Dec 24, 25$2.53Dec 29, 25$2.48Jan 2, 26$2.41Jan 6, 26$2.59Jan 8, 26$2.53Jan 12, 26$2.64Jan 14, 26$2.81Jan 16, 26$2.54Jan 21, 26$2.62Jan 23, 26$2.59Jan 27, 26$2.36Jan 29, 26$2.27Feb 2, 26$2.20Feb 4, 26$2.11Feb 9, 26$2.09Feb 11, 26$2.05Feb 13, 26$2.02Feb 18, 26$2.09Feb 20, 26$2.02Feb 24, 26$2.01Feb 26, 26$2.15Mar 2, 26$2.04Mar 4, 26$2.16Mar 6, 26$2.00Mar 10, 26$1.99Mar 12, 26$1.97Mar 17, 26$1.93Mar 19, 26$1.89Mar 23, 26$1.85Mar 25, 26$1.82Mar 27, 26$1.75Mar 31, 26$1.76Apr 2, 26$1.72Apr 7, 26$1.90Apr 9, 26$1.91Apr 13, 26$2.03Apr 15, 26$2.15Apr 17, 26$2.19Apr 22, 26$2.50Apr 24, 26$2.43Apr 28, 26$2.64Apr 30, 26$2.75May 4, 26$2.65May 6, 26$2.68May 8, 26$3.12May 12, 26$3.28May 14, 26$3.49May 18, 26$3.39May 20, 26$3.59May 22, 26$3.55May 28, 26$4.18Jun 1, 26$3.92Jun 3, 26$3.65Jun 5, 26$3.83Jun 9, 26$4.29Jun 11, 26$4.90Jun 15, 26$4.81Jun 17, 26$4.80Jun 22, 26$5.14Jun 24, 26$5.21Jun 26, 26$5.41Jul 2, 26$5.26
$1.7052-week range$5.41
Loading valuation history…

Fundamentals

Key fundamentals

$2.1B

Market cap

40.3%

Revenue growth (YoY)

18.5%

Gross margin

-$69M

Free cash flow (USD)

-$95.3M

Net debt

Net cash position

5.5%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$281.0MFY 2019$462.3MFY 2020$672.9MFY 2021$1.5BFY 2022$1.1BFY 2023$1.3BFY 2024$1.4BFY 2025$1.9B
$281M$1.9B

Free cash flow by year

2018 → 2025

FY 2018$-154.8MFY 2019$-159.9MFY 2020$-119.2MFY 2021$-283.0MFY 2022$-208.4MFY 2023$-116.5MFY 2024$33.3MFY 2025$-69.0M
-$154.8M-$69M

Gross margin by year

2021 → 2025

FY 2021-5.4%FY 20229.4%FY 202320.3%FY 202426.6%FY 202518.5%
-5.4%18.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

9

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $1.7MToy Andrew · Director, Chief Executive Officer · $1.7MJul 1, 2026Filing
  • Insider sellInsider Sell $11K · 10b5-1 PlanReynoso Jamie L. · CEO, Medicare Advantage · $11.3KJun 18, 2026Filing
  • 8-K eventStar Rating UpdateJun 18, 2026Filing
  • Insider sellInsider Sell $59KOLDAKOWSKI JOSEPH FRANK · VP OF FINANCE AND CONTROLLER · $58.8KJun 17, 2026Filing
  • Insider sellInsider Sell $29KReynoso Jamie L. · CEO, Medicare Advantage · $29.3KJun 16, 2026Filing
  • Insider sellInsider Sell $22KSoares Karen · Chief Legal Officer · $21.6KJun 16, 2026Filing
  • 8-K eventCEO DepartureJun 16, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 12, 2026Filing
  • Insider sellInsider Sell $36K · 10b5-1 PlanReynoso Jamie L. · CEO, Medicare Advantage · $35.8KJun 11, 2026Filing
  • 8-K eventStar Rating RecalculatedJun 10, 2026Filing

Questions

Frequently asked questions

What is Clover Health Investments, Corp.'s market cap?

Clover Health Investments, Corp. (CLOV) has a market capitalization of $2.1B.

What is CLOV's P/E ratio?

A meaningful P/E ratio is not available for CLOV — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is CLOV's price-to-book (P/B) ratio?

CLOV trades at 6.84 times book value per share.

Are insiders buying CLOV stock?

SEC Form 4 filings show no open-market insider buys at Clover Health Investments, Corp. in the last 90 days (9 sells).

Same arena

Related companies in Medical - Healthcare Plans

ALHC

Alignment Healthcare, Inc.

$3.2B

OSCR

Oscar Health, Inc.

$5.8B

MOH

Molina Healthcare, Inc.

$9.1B

CNC

Centene Corporation

$29.2B

HUM

Humana Inc.

$36.8B

CI

Cigna Corporation

$73.7B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.